Neonatal microbiota-epithelial interactions that impact infection.

Area of Science:

• Microbiology
• Immunology
• Neonatal Health

Background:

• Enteric infections are a leading cause of neonatal mortality and morbidity worldwide, persisting despite medical advancements.
• The neonatal period is a critical window for gut microbiota colonization and immune system development, highly sensitive to environmental and host factors.
• Early-life disruptions to the gut microbiota increase newborn susceptibility to enteric infections and systemic spread.

Purpose of the Study:

• To review recent findings on neonatal microbiota-epithelial interactions.
• To understand how these interactions influence susceptibility to intestinal infections in newborns.
• To explore potential microbiota-directed interventions for neonatal enteric infections.

Main Methods:

• Review of current scientific literature on neonatal gut microbiota, immune development, and enteric infections.
• Analysis of studies investigating host-pathogen interactions in the neonatal gut.
• Synthesis of research on microbiota-epithelial signaling pathways in neonates.

Main Results:

• Early-life gut microbiota composition significantly impacts neonatal immune responses and infection susceptibility.
• Microbiota-epithelial interactions play a crucial role in regulating intestinal defense against pathogens in newborns.
• Alterations in gut microbiota are linked to impaired immune function and increased infection risk.

Conclusions:

• Understanding neonatal microbiota-epithelial interactions is key to preventing enteric infections.
• Targeting the gut microbiota offers a promising strategy for developing novel prophylactic and therapeutic interventions for neonates.
• Boosting epithelial defense through microbiota-directed approaches could reduce neonatal mortality and morbidity from enteric infections.